Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.66
Data as of Jul 29
 -0.02 / -0.23%
Today’s Change
6.12
Today|||52-Week Range
31.73
-43.88%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close8.68
Today’s open8.58
Day’s range8.48 - 8.72
Volume26,042
Average volume (3 months)98,284
Market cap$86.4M
Dividend yield--
Data as of 3:59pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.47

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc+0.13+3.04%
LPCNLipocine Inc-0.04-0.58%
SYNSynthetic Biologics ...+0.50+34.25%
ALXAAlexza Pharmaceutica...0.000.00%
Data as of 4:02pm ET, 07/29/2014

Financials

Last reporting dateJuly 30, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.